<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>TT virus and other anelloviruses</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">TT virus and other anelloviruses</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">TT virus and other anelloviruses</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adrian M Di Bisceglie, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Torque teno virus (TTV) was initially detected in patients who developed elevated serum aminotransferase (ALT) concentrations following transfusion and tested negative for all known hepatitis viruses [<a href="#rid1">1-3</a>]. Contrary to what was initially believed, TTV does <strong>not</strong> represent a cause of liver disease or contribute appreciably to the clinical course of patients with existing liver disease. This topic will review the virology, epidemiology, clinical associations, detection, and natural history of TTV and other anelloviruses.</p><p class="headingAnchor" id="H2915970231"><span class="h1">VIROLOGY</span></p><p class="headingAnchor" id="H3503985506"><span class="h2">Classification</span><span class="headingEndMark"> — </span>Torque teno virus (TTV) is classified in the genus <em>Alfatorquevirus</em> within the family Anelloviridae [<a href="#rid4">4</a>]. Torque teno mini virus (TTMV) and Torque teno midi virus (TTMDV), thus named because of their smaller genomes (approximately 2.8 and 3.2 kb) relative to TTV (approximately 3.8 kb), and a large number of related viruses that have been found in a variety of animals and appear to be host species-specific.</p><p class="headingAnchor" id="H3"><span class="h2">Structure and replication of TTV</span><span class="headingEndMark"> — </span>Virions are roughly spherical, approximately 30 nm in diameter, and non-enveloped. The genome is a circular molecule of single-stranded, negative-sense DNA of approximately 3.8 kb and consists of a coding and a noncoding region. The nucleotide (nt) sequence of the coding region has indicated the presence of several open reading frames (ORFs), which overlap extensively, and five to seven virus-encoded proteins (possibly also resulting from different splicing) have been documented in cells transfected with TTV DNA. The mechanisms of TTV genome expression and replication are poorly understood. However, a specific amino acid sequence within the product of ORF1 (which also encodes the putative capsid protein) suggests that replication occurs via a rolling circle mechanism [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H98643178"><span class="h2">Genetic variants</span><span class="headingEndMark"> — </span>Although the genetic organization of different TTV isolates is well conserved, their genomes display a very high level of sequence diversity. Only the noncoding region contains a domain of about 130 nt, which is relatively well conserved among the different isolates. The extremely high degree of DNA polymorphism represents the basis for the subdivision of TTV isolates into a large number of genotypes or species (&gt;10 percent nt divergence), a number that has been increasing with the introduction of new molecular techniques of increasing sensitivity [<a href="#rid5">5</a>]. The different genotypes are classified into five distinct phylogenetic groups designated 1 to 5 (&gt;40 nt divergence), which differ markedly in prevalence. For example, genogroups 1 and 3 are most common, while genogroup 2 is generally rarely detected. Coinfection by multiple TTV genotypes and genogroups is very common [<a href="#rid6">6-8</a>]. There are suggestions that the different genetic variants are antigenically distinct [<a href="#rid9">9</a>]. Whether there are also biological or pathogenic differences between them is essentially unknown.</p><p>Characterization of some TTV genotypes is ongoing [<a href="#rid10">10-12</a>]. Among the most investigated are the ones also known as SEN virus (SENV). Described at first as an independent virus with several variants (designated A to I), SENV was later found to represent a number of genotypes within genogroup 3 TTV [<a href="#rid13">13</a>]. Studies that have tried to elucidate the clinical significance of the SENV have demonstrated its high prevalence, but have not consistently demonstrated any deleterious effect [<a href="#rid14">14-22</a>]. In one study, SENV DNA (types D and H) was detected in 30 percent of 286 patients with a history of transfusion compared with 3 percent of 97 nontransfused controls [<a href="#rid22">22</a>]. The risk of infection increased in proportion to the number of units transfused. SENV DNA was detected in 11 of 12 patients with transfusion-associated non-A to E hepatitis compared with 55 of 225 who did not develop hepatitis. SENV DNA persisted for more than one year in 45 percent of patients and up to 12 years in 13 percent of patients. The vast majority of SENV-infected recipients did not develop hepatitis. </p><p class="headingAnchor" id="H2940703155"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Anelloviruses represent a conspicuous, essentially constant component of the (normal) human virome. Few studies have investigated Torque teno mini virus (TTMV) and Torque teno midi virus (TTMDV), but their general and epidemiologic features do not seem to differ substantially from those of TTV [<a href="#rid23">23,24</a>]. </p><p class="headingAnchor" id="H210005795"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>TTV is highly prevalent worldwide, with prevalence rates of over 80 to 90 percent among healthy adults [<a href="#rid1">1,6,25-42</a>]. Anellovirus infections are acquired early in life [<a href="#rid37">37-39</a>]. TTV has been detected in the great majority of plasma or other body fluids from children aged two years or less [<a href="#rid9">9,43</a>]. As TTV is blood-borne, rates are higher in individuals who receive blood transfusions [<a href="#rid34">34-36</a>]. </p><p class="headingAnchor" id="H2638591252"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>TTV has been detected in nearly all tissues of the body and in biological fluids, except the intact central nervous system (CNS) [<a href="#rid44">44</a>]. It is excreted with stool, urine, saliva, and nasal fluid [<a href="#rid6">6</a>]. Since TTV appears to be highly resistant in the environment, it has the potential to be transmitted through many routes and serves as an indicator of general viral contamination of the environment [<a href="#rid45">45</a>]. Evidence of vertical transmission between mothers and their infants has been demonstrated in some studies [<a href="#rid39">39</a>]. Indirect evidence has suggested that hematopoietic cells, possibly T lymphocytes, are an important source of the virus found in plasma; however, the full range of cell types that support TTV replication within the body is unknown [<a href="#rid46">46,47</a>]. </p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL IMPLICATIONS</span><span class="headingEndMark"> — </span>The clinical significance of TTV infections remains uncertain. </p><p class="headingAnchor" id="H2316290232"><span class="h2">Lack of association with acute or chronic liver disease</span><span class="headingEndMark"> — </span>Contrary to what was initially proposed, it is now well established that TTV infections are not a cause of liver disease. It has been suggested that TTV may represent part of the normal human virome [<a href="#rid48">48</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute hepatitis</strong> — Several observations have led to the conclusion that TTV is <strong>not</strong> a cause of acute hepatitis [<a href="#rid49">49-53</a>]. In a study involving healthy blood donors and patients who received a blood transfusion in a variety of settings, new TTV infection was observed in 26 percent of 182 transfused patients of whom 23 percent developed non-A to E hepatitis [<a href="#rid49">49</a>]. However, this rate was not significantly different when compared with patients who developed non-A to E hepatitis without new TTV infection, suggesting that TTV was not the cause of the unknown hepatitis. Similarly, the acquisition of TTV following liver or bone marrow transplantation has not been associated with clinical or biochemical evidence of hepatitis [<a href="#rid51">51</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic liver disease</strong> — Most studies have found <strong>no association</strong> between TTV infection and biochemical or histologic evidence of liver damage in patients with chronic hepatic disease of unknown cause [<a href="#rid34">34,36,49,54,55</a>]. </p><p></p><p>Studies have not consistently demonstrated an increase in prevalence of TTV in patients with chronic liver disease [<a href="#rid54">54,55</a>]. However, even in those that have demonstrated an increase in prevalence of TTV in patients with liver disease, TTV did not appear to contribute to liver injury [<a href="#rid34">34,54,56</a>]. These reports of increased prevalence of TTV among patients with chronic liver disease may be explained on the basis of shared risk factors for infection rather than TTV being the cause or an aggravating factor of the liver disease [<a href="#rid57">57-59</a>].</p><p>TTV DNA has been sought in a number of other settings related to liver disease. TTV does not appear to serve as a trigger for autoimmune hepatitis [<a href="#rid60">60</a>] and has not been associated with cryoglobulinemia [<a href="#rid61">61</a>]. TTV does not appear to interfere with treatment of hepatitis C virus with interferon; discrepant reports have been published as to whether it may be cleared during interferon treatment [<a href="#rid3">3,42,62</a>]. Other studies have found no association between TTV and increased risk of hepatocellular carcinoma in patients with a variety of other predisposing conditions. [<a href="#rid63">63,64</a>].</p><p class="headingAnchor" id="H316458031"><span class="h2">Other disease associations of unclear significance</span><span class="headingEndMark"> — </span>TTV has been associated with several disease conditions, but confirmatory studies are needed, and a causal association has not been established. Determining if associations with any other diseases are causal is challenging because of the wide prevalence of the infection in the general population, the presence of the virions in many tissues, the existence of numerous genetic variants of the viruses, the frequent occurrence of coinfections by two or more such variants, and the wide range of viral loads that can be present in individual patients. In fact, these characteristics also challenge the adequacy of traditional approaches for establishing a causal relationship between an infectious agent and a disease [<a href="#rid65">65</a>].</p><p>TTV has been associated with systemic lupus erythematosus [<a href="#rid62">62</a>], pancreatic cancer [<a href="#rid66">66</a>], diabetes mellitus [<a href="#rid61">61</a>], poor outcomes in patients with laryngeal cancer [<a href="#rid67">67</a>], periodontal disease [<a href="#rid68">68</a>], multiple sclerosis [<a href="#rid69">69</a>], cryptogenic fever of children [<a href="#rid70">70</a>], and endophthalmitis [<a href="#rid71">71</a>]. TTV may possibly be a cause of acute respiratory diseases in children [<a href="#rid72">72,73</a>] and an aggravating factor in patients with asthma [<a href="#rid74">74</a>], bronchiectasis [<a href="#rid75">75</a>], and chronic obstructive pulmonary disease [<a href="#rid76">76</a>]. Changes in TTV plasma loads have been proposed as an indicator of immune function in immunosuppressed individuals and TTV patterns may be a marker of disease [<a href="#rid47">47,77-82</a>]. (See <a class="local">'Viral load'</a> below.)</p><p class="headingAnchor" id="H3910712257"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H2562967728"><span class="h2">Viral load</span><span class="headingEndMark"> — </span>The diagnosis of infection relies solely upon detection of TTV DNA by polymerase chain reaction (PCR) assay [<a href="#rid44">44</a>]. However, there are no commercially available assays. Plasma loads of TTV vary widely in individual patients. For example, in a study of healthy subjects they ranged between 10<sup>3</sup> and 10<sup>8</sup> DNA copy numbers per mL [<a href="#rid83">83</a>]. These variations reflect the replicating activity of TTV in the body as well as the number of genetic variants of the virus carried at the time of testing, and the immunological status of the host [<a href="#rid42">42,84</a>]. It appears that immunosuppression may be associated with increasing levels of TTV replication, suggesting a role for the immune system in controlling TTV infection [<a href="#rid85">85</a>]. A variable fraction of the TTV virions found in plasma is bound to presumably virus-specific immunoglobulin G (IgG) or IgM. Whether these immunocomplexes remain infectious is unknown [<a href="#rid23">23</a>]. </p><p class="headingAnchor" id="H2731492130"><span class="h2">Other</span><span class="headingEndMark"> — </span>There are no easy-to-perform tissue culture methods for growing TTV, and reliable serological methods for studying the antiviral antibody responses are lacking [<a href="#rid9">9,24,86</a>]. Anti-TTV IgM antibodies appear in blood 10 to 21 weeks after TTV infection and gradually decrease 5 to 11 weeks after their initial appearance [<a href="#rid87">87</a>]. Anti-TTV IgG antibodies emerge around 16 weeks of infection, reach maximum concentrations at 5 months, and are detectable for four or more years. </p><p class="headingAnchor" id="H2646304668"><span class="h1">NATURAL HISTORY</span></p><p class="headingAnchor" id="H3232947034"><span class="h2">Viral clearance</span><span class="headingEndMark"> — </span>Many aspects of the natural history of TTV, including the frequency with which acute infection leads to viral clearance, remain poorly defined. It has been demonstrated that TTV is shed into and removed from the bloodstream at rates comparable to other chronic viremia-inducing viruses such as the hepatitis viruses B and C [<a href="#rid42">42</a>]. In one study that included 48 patients with TTV, chronic infection was observed in 31 cases (86 percent) with TTV persistence for a mean duration of three years [<a href="#rid88">88</a>]. These reports suggest an annual clearance of viral persistence of approximately 1 to 7 percent [<a href="#rid35">35,88</a>]. In another study that included 21 viremic subjects, 14 (67 percent) cleared TTV within five years, but 7 (33 percent) were viremic during 22 years of follow-up [<a href="#rid49">49</a>]. However, these studies were performed using virus detection assays that, due to limitations in sensitivity, were incapable of discriminating between true virus eradications and fluctuations of virus replication that brought the viral burden under the lower limit of detection of the specific assay used.</p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Torque teno virus (TTV) is a non-enveloped single-stranded circular DNA virus classified in the genus <em>Alfatorquevirus</em> within the family Anelloviridae. This family also includes two additional pervasive human viruses, Torque teno mini virus (TTMV) and Torque teno midi virus (TTMDV). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anelloviral infections are acquired early in life and represent a large part of the human virome. TTV has been detected in nearly all tissues of the body except the intact central nervous system and in biological fluids. It is excreted in stool, urine, saliva, and nasal fluid. Since TTV appears to be highly resistant in the environment, it has the potential to be transmitted through many routes and serves as an indicator of general viral contamination of the environment. Evidence of vertical transmission between mothers and their infants has been demonstrated in some studies. Few studies have investigated TTMV and TTMDV, but their general and epidemiologic features do not seem to differ substantially from those of TTV. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mechanisms of TTV genome expression and replication are poorly understood. However, a specific amino acid sequence within the product of open reading frame, ORF1, which also encodes the putative capsid protein, suggests that replication occurs via a rolling circle mechanism. (See <a class="local">'Structure and replication of TTV'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The extremely high degree of DNA polymorphism represents the basis for the subdivision of TTV isolates into a large number of genotypes or species (&gt;10 percent nt divergence). The different genotypes are classified into five distinct phylogenetic groups designated 1 to 5 (&gt;40 nt divergence), which differ markedly in prevalence. (See <a class="local">'Genetic variants'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical significance of TTV infections remains uncertain. However, contrary to what was initially proposed, it is now well established that TTV infections are <strong>not</strong> significant causes of liver disease. It has been suggested that TT virus may represent part of the <strong>normal human virome. </strong>(See <a class="local">'Clinical implications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many aspects of the natural history of TTV, including the frequency with which acute infection leads to viral clearance, remain poorly defined. (See <a class="local">'Viral clearance'</a> above.)</p><p></p><p class="headingAnchor" id="H26843599"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Mauro Bendinelli, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241:92.</a></li><li><a class="nounderline abstract_t">Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10:1.</a></li><li><a class="nounderline abstract_t">Bonis PA. TT virus. J Am Soc Nephrol 1999; 10:1828.</a></li><li class="breakAll">Biagini P, Bendinelli M, Hino S, et al. Family Anelloviridae. In: IXth Report of the International Committee for the Taxonomy of Viruses, King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (Eds), Elsevier Academic Press, Amsterdam 2012. p.331.</li><li><a class="nounderline abstract_t">Bzhalava D, Ekström J, Lysholm F, et al. Phylogenetically diverse TT virus viremia among pregnant women. Virology 2012; 432:427.</a></li><li><a class="nounderline abstract_t">Bendinelli M, Pistello M, Maggi F, et al. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001; 14:98.</a></li><li><a class="nounderline abstract_t">Biagini P. Human circoviruses. Vet Microbiol 2004; 98:95.</a></li><li><a class="nounderline abstract_t">Hino S, Miyata H. Torque teno virus (TTV): current status. Rev Med Virol 2007; 17:45.</a></li><li><a class="nounderline abstract_t">Chen T, Väisänen E, Mattila PS, et al. Antigenic diversity and seroprevalences of Torque teno viruses in children and adults by ORF2-based immunoassays. J Gen Virol 2013; 94:409.</a></li><li><a class="nounderline abstract_t">Hijikata M, Takahashi K, Mishiro S. Complete circular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes. Virology 1999; 260:17.</a></li><li><a class="nounderline abstract_t">Takahashi K, Iwasa Y, Hijikata M, Mishiro S. Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol 2000; 145:979.</a></li><li><a class="nounderline abstract_t">Hallett RL, Clewley JP, Bobet F, et al. Characterization of a highly divergent TT virus genome. J Gen Virol 2000; 81:2273.</a></li><li><a class="nounderline abstract_t">Tanaka Y, Primi D, Wang RY, et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001; 183:359.</a></li><li><a class="nounderline abstract_t">Akiba J, Umemura T, Alter HJ, et al. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion 2005; 45:1084.</a></li><li><a class="nounderline abstract_t">Dai CY, Yu ML, Lin ZY, et al. Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan. Dig Dis Sci 2004; 49:1181.</a></li><li><a class="nounderline abstract_t">Rigas B, Hasan I, Rehman R, et al. Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C. Lancet 2001; 358:1961.</a></li><li><a class="nounderline abstract_t">Umemura T, Alter HJ, Tanaka E, et al. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002; 35:953.</a></li><li><a class="nounderline abstract_t">Lin JG, Goto T, Nakane K, et al. Clinical significance of SEN-virus on interferon response in chronic hepatitis C patients. J Gastroenterol Hepatol 2003; 18:1144.</a></li><li><a class="nounderline abstract_t">Yoshida EM, Buczkowski AK, Giulivi A, et al. A cross-sectional study of SEN virus in liver transplant recipients. Liver Transpl 2001; 7:521.</a></li><li><a class="nounderline abstract_t">Shibata M, Wang RY, Yoshiba M, et al. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis 2001; 184:400.</a></li><li><a class="nounderline abstract_t">Tangkijvanich P, Theamboonlers A, Sriponthong M, et al. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study. Am J Gastroenterol 2003; 98:2500.</a></li><li><a class="nounderline abstract_t">Umemura T, Yeo AE, Sottini A, et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33:1303.</a></li><li><a class="nounderline abstract_t">Maggi F, Bendinelli M. Immunobiology of the Torque teno viruses and other anelloviruses. Curr Top Microbiol Immunol 2009; 331:65.</a></li><li><a class="nounderline abstract_t">Spandole S, Cimponeriu D, Berca LM, Mihăescu G. Human anelloviruses: an update of molecular, epidemiological and clinical aspects. Arch Virol 2015; 160:893.</a></li><li><a class="nounderline abstract_t">Maggi F, Fornai C, Morrica A, et al. High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment. J Infect Dis 1999; 180:838.</a></li><li><a class="nounderline abstract_t">Nakano T, Park YM, Mizokami M, et al. TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea. J Hepatol 1999; 30:389.</a></li><li><a class="nounderline abstract_t">Niel C, de Oliveira JM, Ross RS, et al. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 1999; 57:259.</a></li><li><a class="nounderline abstract_t">Tanaka Y, Mizokami M, Orito E, et al. A new genotype of TT virus (TTV) infection among Colombian native Indians. J Med Virol 1999; 57:264.</a></li><li><a class="nounderline abstract_t">Handa A, Dickstein B, Young NS, Brown KE. Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion 2000; 40:245.</a></li><li><a class="nounderline abstract_t">Al-Moslih MI, Abuodeh RO, Hu YW. Detection and genotyping of TT virus in healthy and subjects with HBV or HCV in different populations in the United Arab Emirates. J Med Virol 2004; 72:502.</a></li><li><a class="nounderline abstract_t">Biagini P, Gallian P, Touinssi M, et al. High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems. Transfusion 2000; 40:590.</a></li><li><a class="nounderline abstract_t">Huang LY, Oystein Jonassen T, Hungnes O, Grinde B. High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors. J Med Virol 2001; 64:381.</a></li><li><a class="nounderline abstract_t">Zhong S, Yeo W, Lin CK, et al. Quantitative and genotypic analysis of TT virus infection in Chinese blood donors. Transfusion 2001; 41:1001.</a></li><li><a class="nounderline abstract_t">Takayama S, Miura T, Matsuo S, et al. Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs. Br J Haematol 1999; 104:626.</a></li><li><a class="nounderline abstract_t">Prati D, Lin YH, De Mattei C, et al. A prospective study on TT virus infection in transfusion-dependent patients with beta-thalassemia. Blood 1999; 93:1502.</a></li><li><a class="nounderline abstract_t">Chen BP, Rumi MG, Colombo M, et al. TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates. Blood 1999; 94:4333.</a></li><li><a class="nounderline abstract_t">Komatsu H, Inui A, Sogo T, et al. TTV infection in children born to mothers infected with TTV but not with HBV, HCV, or HIV. J Med Virol 2004; 74:499.</a></li><li><a class="nounderline abstract_t">Davidson F, MacDonald D, Mokili JL, et al. Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 1999; 179:1070.</a></li><li><a class="nounderline abstract_t">Xin X, Xiaoguang Z, Ninghu Z, et al. Mother-to-infant vertical transmission of transfusion transmitted virus in South China. J Perinat Med 2004; 32:404.</a></li><li><a class="nounderline abstract_t">Goto K, Sugiyama K, Terabe K, et al. Detection rates of TT virus among children who visited a general hospital in Japan. J Med Virol 1999; 57:405.</a></li><li><a class="nounderline abstract_t">Welch J, Bienek C, Gomperts E, Simmonds P. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products. Transfusion 2006; 46:1951.</a></li><li><a class="nounderline abstract_t">Maggi F, Pistello M, Vatteroni M, et al. Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol 2001; 75:11999.</a></li><li><a class="nounderline abstract_t">Naganuma M, Tominaga N, Miyamura T, et al. TT virus prevalence, viral loads and genotypic variability in saliva from healthy Japanese children. Acta Paediatr 2008; 97:1686.</a></li><li><a class="nounderline abstract_t">Maggi F, Bendinelli M. Human anelloviruses and the central nervous system. Rev Med Virol 2010; 20:392.</a></li><li><a class="nounderline abstract_t">Carducci A, Verani M, Lombardi R, et al. Environmental survey to assess viral contamination of air and surfaces in hospital settings. J Hosp Infect 2011; 77:242.</a></li><li><a class="nounderline abstract_t">Maggi F, Focosi D, Albani M, et al. Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia. J Virol 2010; 84:6891.</a></li><li><a class="nounderline abstract_t">Focosi D, Macera L, Boggi U, et al. Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells. J Gen Virol 2015; 96:115.</a></li><li><a class="nounderline abstract_t">Wang W, Zhang X, Xu Y, et al. Viral categorization and discovery in human circulation by transcriptome sequencing. Biochem Biophys Res Commun 2013; 436:525.</a></li><li><a class="nounderline abstract_t">Matsumoto A, Yeo AE, Shih JW, et al. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 1999; 30:283.</a></li><li><a class="nounderline abstract_t">Parquet MC, Yatsuhashi H, Koga M, et al. Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown etiology. J Hepatol 1999; 31:985.</a></li><li><a class="nounderline abstract_t">Kanda Y, Tanaka Y, Kami M, et al. TT virus in bone marrow transplant recipients. Blood 1999; 93:2485.</a></li><li><a class="nounderline abstract_t">García-Álvarez M, Berenguer J, Alvarez E, et al. Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis 2013; 32:289.</a></li><li><a class="nounderline abstract_t">Piaggio F, Dodi F, Bottino G, et al. Torque Teno Virus--cause of viral liver disease following liver transplantation: a case report. Transplant Proc 2009; 41:1378.</a></li><li><a class="nounderline abstract_t">Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998; 352:195.</a></li><li><a class="nounderline abstract_t">Cleavinger PJ, Persing DH, Li H, et al. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol 2000; 95:772.</a></li><li><a class="nounderline abstract_t">Mizokami M, Albrecht JK, Kato T, et al. TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group. J Hepatol 2000; 32:339.</a></li><li><a class="nounderline abstract_t">Ikeda H, Takasu M, Inoue K, et al. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. J Hepatol 1999; 30:205.</a></li><li><a class="nounderline abstract_t">Kasirga E, Sanlidag T, Akçali S, et al. Clinical significance of TT virus infection in children with chronic hepatitis B. Pediatr Int 2005; 47:300.</a></li><li><a class="nounderline abstract_t">Nishiguchi S, Enomoto M, Shiomi S, et al. GB virus C and TT virus infections in Japanese patients with autoimmune hepatitis. J Med Virol 2002; 66:258.</a></li><li><a class="nounderline abstract_t">Charlton M, Adjei P, Poterucha J, et al. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28:839.</a></li><li><a class="nounderline abstract_t">Guney C, Kadayifci A, Savas MC, et al. Frequency of hepatitis G virus and transfusion-transmitted virus infection in type II diabetes mellitus. Int J Clin Pract 2005; 59:206.</a></li><li><a class="nounderline abstract_t">Gergely P Jr, Pullmann R, Stancato C, et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol 2005; 116:124.</a></li><li><a class="nounderline abstract_t">Tagger A, Donato F, Ribero ML, et al. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study. Hepatology 1999; 30:294.</a></li><li><a class="nounderline abstract_t">Kew MC. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. J Viral Hepat 2013; 20:149.</a></li><li><a class="nounderline abstract_t">Westman G, Schoofs C, Ingelsson M, et al. Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease. PLoS One 2020; 15:e0227670.</a></li><li><a class="nounderline abstract_t">Tomasiewicz K, Modrzewska R, Lyczak A, Krawczuk G. TT virus infection and pancreatic cancer: relationship or accidental coexistence. World J Gastroenterol 2005; 11:2847.</a></li><li><a class="nounderline abstract_t">Szládek G, Juhász A, Kardos G, et al. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol 2005; 58:402.</a></li><li><a class="nounderline abstract_t">Rotundo R, Maggi F, Nieri M, et al. TT virus infection of periodontal tissues: a controlled clinical and laboratory pilot study. J Periodontol 2004; 75:1216.</a></li><li><a class="nounderline abstract_t">Borkosky SS, Whitley C, Kopp-Schneider A, et al. Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS One 2012; 7:e32160.</a></li><li><a class="nounderline abstract_t">McElvania TeKippe E, Wylie KM, Deych E, et al. Increased prevalence of anellovirus in pediatric patients with fever. PLoS One 2012; 7:e50937.</a></li><li><a class="nounderline abstract_t">Lee AY, Akileswaran L, Tibbetts MD, et al. Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencing. Ophthalmology 2015; 122:524.</a></li><li><a class="nounderline abstract_t">Maggi F, Pifferi M, Fornai C, et al. TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol 2003; 77:2418.</a></li><li><a class="nounderline abstract_t">Biagini P, Charrel RN, de Micco P, de Lamballerie X. Association of TT virus primary infection with rhinitis in a newborn. Clin Infect Dis 2003; 36:128.</a></li><li><a class="nounderline abstract_t">Pifferi M, Maggi F, Andreoli E, et al. Associations between nasal torquetenovirus load and spirometric indices in children with asthma. J Infect Dis 2005; 192:1141.</a></li><li><a class="nounderline abstract_t">Pifferi M, Maggi F, Caramella D, et al. High torquetenovirus loads are correlated with bronchiectasis and peripheral airflow limitation in children. Pediatr Infect Dis J 2006; 25:804.</a></li><li><a class="nounderline abstract_t">Feyzioğlu B, Teke T, Ozdemir M, et al. The presence of Torque teno virus in chronic obstructive pulmonary disease. Int J Clin Exp Med 2014; 7:3461.</a></li><li><a class="nounderline abstract_t">Focosi D, Maggi F, Albani M, et al. Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. J Clin Virol 2010; 47:189.</a></li><li><a class="nounderline abstract_t">De Vlaminck I, Khush KK, Strehl C, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 2013; 155:1178.</a></li><li><a class="nounderline abstract_t">Béland K, Dore-Nguyen M, Gagné MJ, et al. Torque Teno virus in children who underwent orthotopic liver transplantation: new insights about a common pathogen. J Infect Dis 2014; 209:247.</a></li><li><a class="nounderline abstract_t">Görzer I, Jaksch P, Kundi M, et al. Pre-transplant plasma Torque Teno virus load and increase dynamics after lung transplantation. PLoS One 2015; 10:e0122975.</a></li><li><a class="nounderline abstract_t">Gore EJ, Gomes-Neto AW, Wang L, et al. Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients. J Clin Med 2020; 9.</a></li><li><a class="nounderline abstract_t">Doberer K, Schiemann M, Strassl R, et al. Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial. Am J Transplant 2020; 20:2081.</a></li><li><a class="nounderline abstract_t">Pistello M, Morrica A, Maggi F, et al. TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol 2001; 63:189.</a></li><li><a class="nounderline abstract_t">Maggi F, Pifferi M, Michelucci A, et al. Torque teno virus viremia load size in patients with selected congenital defects of innate immunity. Clin Vaccine Immunol 2011; 18:692.</a></li><li><a class="nounderline abstract_t">Masouridi-Levrat S, Pradier A, Simonetta F, et al. Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2016; 51:440.</a></li><li><a class="nounderline abstract_t">Mankotia DS, Irshad M. Cloning and expression of N22 region of Torque Teno virus (TTV) genome and use of peptide in developing immunoassay for TTV antibodies. Virol J 2014; 11:96.</a></li><li><a class="nounderline abstract_t">Reshetnyak VI, Maev IV, Burmistrov AI, et al. Torque teno virus in liver diseases: On the way towards unity of view. World J Gastroenterol 2020; 26:1691.</a></li><li><a class="nounderline abstract_t">Lefrère JJ, Roudot-Thoraval F, Lefrère F, et al. Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood 2000; 95:347.</a></li></ol></div><div id="topicVersionRevision">Topic 3629 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9405239" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10446953" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : TT virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10446953" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : TT virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22819835" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Phylogenetically diverse TT virus viremia among pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11148004" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14741121" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Human circoviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17146841" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Torque teno virus (TTV): current status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114629" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Antigenic diversity and seroprevalences of Torque teno viruses in children and adults by ORF2-based immunoassays.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10405352" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Complete circular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10881684" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10950985" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Characterization of a highly divergent TT virus genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11133366" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15987351" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15387343" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11747922" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11915044" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12974900" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical significance of SEN-virus on interferon response in chronic hepatitis C patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11443581" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A cross-sectional study of SEN virus in liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11471096" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638355" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11343260" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : SEN virus infection and its relationship to transfusion-associated hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19230558" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Immunobiology of the Torque teno viruses and other anelloviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25680568" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Human anelloviruses: an update of molecular, epidemiological and clinical aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10438375" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10190719" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10022797" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : High prevalence of TT virus infection in Brazilian blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10022798" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A new genotype of TT virus (TTV) infection among Colombian native Indians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10686010" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Prevalence of the newly described human circovirus, TTV, in United States blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14748076" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Detection and genotyping of TT virus in healthy and subjects with HBV or HCV in different populations in the United Arab Emirates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10827265" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11424130" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11493731" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Quantitative and genotypic analysis of TT virus infection in Chinese blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086806" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10029577" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A prospective study on TT virus infection in transfusion-dependent patients with beta-thalassemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10590078" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15368510" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : TTV infection in children born to mothers infected with TTV but not with HBV, HCV, or HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10191206" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Early acquisition of TT virus (TTV) in an area endemic for TTV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15493715" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mother-to-infant vertical transmission of transfusion transmitted virus in South China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10089054" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Detection rates of TT virus among children who visited a general hospital in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17076851" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711590" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18671690" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : TT virus prevalence, viral loads and genotypic variability in saliva from healthy Japanese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20925048" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Human anelloviruses and the central nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21277649" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Environmental survey to assess viral contamination of air and surfaces in hospital settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20410268" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25304651" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23764402" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Viral categorization and discovery in human circulation by transcriptome sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10385668" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Transfusion-associated TT virus infection and its relationship to liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10604570" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10194426" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : TT virus in bone marrow transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22983402" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19460564" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Torque Teno Virus--cause of viral liver disease following liver transplantation: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9683209" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Presence of a newly described human DNA virus (TTV) in patients with liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10710073" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10707876" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10068097" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15910455" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical significance of TT virus infection in children with chronic hepatitis B.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11782937" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : GB virus C and TT virus infections in Japanese patients with autoimmune hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9731581" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15854198" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Frequency of hepatitis G virus and transfusion-transmitted virus infection in type II diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15894513" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10385670" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23383653" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31917803" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15884138" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : TT virus infection and pancreatic cancer: relationship or accidental coexistence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15790705" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15515336" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : TT virus infection of periodontal tissues: a controlled clinical and laboratory pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22384166" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23226428" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Increased prevalence of anellovirus in pediatric patients with fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25439613" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12551979" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12491220" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Association of TT virus primary infection with rhinitis in a newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16136454" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Associations between nasal torquetenovirus load and spirometric indices in children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16940838" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : High torquetenovirus loads are correlated with bronchiectasis and peripheral airflow limitation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25419383" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The presence of Torque teno virus in chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20034850" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24267896" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Temporal response of the human virome to immunosuppression and antiviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23922368" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Torque Teno virus in children who underwent orthotopic liver transplantation: new insights about a common pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25894323" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pre-transplant plasma Torque Teno virus load and increase dynamics after lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32041187" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32034850" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11170056" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21325487" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Torque teno virus viremia load size in patients with selected congenital defects of innate immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26551776" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24884576" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Cloning and expression of N22 region of Torque Teno virus (TTV) genome and use of peptide in developing immunoassay for TTV antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32351287" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Torque teno virus in liver diseases: On the way towards unity of view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10607723" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
